BIOAGE LABS, INC. (BIOA) Return on equity 2024–2025
BIOAGE LABS, INC. (BIOA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-29.6%FY2025 · since FY2024: -22.0% → -29.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -29.6% | -7.6 pp |
| FY2024 | -22.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BIOA financial trends
BIOA RevenueBIOA Net incomeBIOA Net marginBIOA Gross profitBIOA Gross marginBIOA Operating incomeBIOA Operating marginBIOA Operating cash flowBIOA Free cash flowBIOA Capital expendituresBIOA Stock buybacksBIOA Dividends paidBIOA Total assetsBIOA Total liabilitiesBIOA Shareholders’ equityBIOA overview →